134 related articles for article (PubMed ID: 30839339)
21. Assessment of histologic criteria in the diagnosis of mycosis fungoides.
Naraghi ZS; Seirafi H; Valikhani M; Farnaghi F; Kavusi S; Dowlati Y
Int J Dermatol; 2003 Jan; 42(1):45-52. PubMed ID: 12581144
[TBL] [Abstract][Full Text] [Related]
22. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides.
Nickoloff BJ
Am J Dermatopathol; 1988 Dec; 10(6):469-77. PubMed ID: 3064629
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
26. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
27. ALK Expression is a Rare Finding in Mycosis Fungoides.
Covington M; Cassarino D; Abdulla F
Am J Dermatopathol; 2017 May; 39(5):342-343. PubMed ID: 28426485
[TBL] [Abstract][Full Text] [Related]
28. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
29. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
30. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
Furlan FC; Pereira BA; Sotto MN; Sanches JA
Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
[TBL] [Abstract][Full Text] [Related]
31. Interstitial Mycosis Fungoides With Lichen Sclerosus-Like Clinical and Histopathological Features.
Tekin B; Kempf W; Seckin D; Ergun T; Yucelten D; Demirkesen C
Am J Dermatopathol; 2016 Feb; 38(2):138-43. PubMed ID: 26630682
[TBL] [Abstract][Full Text] [Related]
32. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
[TBL] [Abstract][Full Text] [Related]
33. Genetic markers associated with progression in early mycosis fungoides.
Johnson VE; Vonderheid EC; Hess AD; Eischen CM; McGirt LY
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1431-5. PubMed ID: 24171863
[TBL] [Abstract][Full Text] [Related]
34. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
35. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
36. TOX acts an oncological role in mycosis fungoides.
Yu X; Luo Y; Liu J; Liu Y; Sun Q
PLoS One; 2015; 10(3):e0117479. PubMed ID: 25811617
[TBL] [Abstract][Full Text] [Related]
37. Hypopigmented mycosis fungoides: case reports and literature review.
Qari MS; Li N; Demierre MF
J Cutan Med Surg; 2000 Jul; 4(3):142-8. PubMed ID: 11003719
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
39. Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea.
Su LD; Kim YH; LeBoit PE; Swetter SM; Kohler S
J Cutan Pathol; 2002 Mar; 29(3):135-41. PubMed ID: 11972709
[TBL] [Abstract][Full Text] [Related]
40. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
